$29.53+1.84 (+6.64%)
Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. in the Healthcare sector is trading at $29.53 with a market capitalization of $2.4B. Wall Street consensus targets $28.86 (14 analysts), implying a -2.3% move over the next 12 months. The stock is currently near its 52-week high of $30.20, remaining 40.4% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $828.80M↑ | $821.46M↓ | $851.57M↓ | $869.23M↑ | $770.50M |
| Gross Profit | $799.31M↑ | $790.70M↓ | $821.16M↓ | $840.70M↑ | $742.16M |
| Operating Income | $83.84M↑ | $47.64M↓ | $119.52M↓ | $142.30M↑ | $78.50M |
| Net Income | $4.11M↑ | -$1.18B↓ | $36.25M↑ | $30.13M↑ | $8.37M |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilit...
Hospital stocks are adapting to shifting care trends, with Tenet Healthcare, Universal Health, Acadia Healthcare and Community Health Systems in focus.
The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.
ACHC is shifting from expansion to returns, raising EBITDA guidance as mature facilities and rising demand support its turnaround strategy.
Is ACHC a good stock to buy? We came across a bullish thesis on Acadia Healthcare Company, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on ACHC. Acadia Healthcare Company, Inc.’s share was trading at $24.99 as of June 16th. ACHC’s trailing and forward P/E were 19.82 and 16.67 respectively according to […]
In its recent earnings report, Acadia Healthcare Company posted a 7.6% year-on-year revenue increase that exceeded analyst expectations, while its guidance for the next quarter’s revenue and EPS came in below prior estimates. Although management raised full-year guidance more than many hospital peers and emphasized disciplined execution in behavioral health services, investors focused on the softer near-term outlook for revenue and profitability. Next, we’ll examine how Acadia’s stronger...